Company: APXIF
Filing Date: 2025-07-18
Form Type: F-4/A
Source: 0001213900-25-065703
Chunk: 384

Company: APx Acquisition Corp. I
Filing Date: 2025-07-18
Form: F-4/A
Chunk 384
---
 Our clinical knowledge and expertise will enable us to capture market share as we expand through additional partnerships, aligning ourselves with the global shift towards personalized medicine, meeting the increasing demand for precision diagnostics, and playing a key role in improving patient care and treatment. Facilities Our current headquarters are located in Rosario, Argentina, where we lease about 146 square meters of office and laboratory space pursuant to leases with a third party and with CIBIC that expire on December 31, 2027 and October 30, 2026, respectively. In our headquarters, new tests and algorithms are developed and commercialized samples from Rewell and Heritas are processed. We also lease an integrated office space, consisting of two apartments, from Compañía de Insumos y Granos SA., in Rosario. The agreement will expire on December 31, 2026. We expect to source suitable additional or alternative spaces that will be available to accommodate our operations as we grow and scale our business. We believe that our facilities are adequate and suitable for our current needs. For more information on our existing facilities and our expansion plans, see “ — Market Opportunity.” 191 Wet-Labs Our Argentine Wet -Labis located in Rosario, Argentina, where samples from both the Rewell platform and Heritas Diagnostics operations are analyzed and processed. In the laboratory we extract the DNA from either the blood, tissue, microbiome, or saliva sample, and process it utilizing Ilumina® Next Generation Sequencing equipment that allows complete genome sequencing. Once processed, advanced bioinformatics are applied to interpret complex genetic data and generate results. Rewell’s results are automatically generated and presented within the Rewell platform, while Heritas Diagnostics utilizes a team of medical geneticists to write reports that are signed by our biochemist to certify the results provided to physicians and/or patients. Our Argentine Wet -Labis certified with ISO 9001 quality standards, alongside external quality control procedures by EMQN/CAP, to provide the highest testing quality. Operating a laboratory allows us to generate synergies by vertically integrating the supply chain for both Rewell and Heritas Diagnostic, enabling us to manage costs, production, inventory, distribution, and product quality. Competition Our competitors include companies that offer genetic testing, screening and consulting services in the medical and consumer space, including specialty and reference laboratories that offer traditional single- and multi -genetests. Principal direct and indirect competitors include companies such as Synlab; Centogene N.V.; Invitae Corporation; Mendelics Anál